These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 9474471)

  • 1. Clinical pharmacokinetics and pharmacodynamics of torasemide.
    Knauf H; Mutschler E
    Clin Pharmacokinet; 1998 Jan; 34(1):1-24. PubMed ID: 9474471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
    Gentilini P; La Villa G; Marra F; Carloni V; Melani L; Foschi M; Cotrozzi G; Quartini M; Chibbaro G; Tommasi AC; Bernareggi A; Simoni A; Buzzelli G; Laffi G
    J Hepatol; 1996 Oct; 25(4):481-90. PubMed ID: 8912147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of loop diuretics.
    Brater DC
    Drugs; 1991; 41 Suppl 3():14-22. PubMed ID: 1712712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics.
    Knauf H; Spahn H; Mutschler E
    Drugs; 1991; 41 Suppl 3():23-34. PubMed ID: 1712713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of torasemide in health and disease.
    Brater DC
    J Cardiovasc Pharmacol; 1993; 22 Suppl 3():S24-31. PubMed ID: 7506334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
    Lesne M
    Arzneimittelforschung; 1988 Jan; 38(1A):160-3. PubMed ID: 3370062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA; Buckley MM
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.
    Risler T; Krämer B; Müller GA
    Drugs; 1991; 41 Suppl 3():69-79. PubMed ID: 1712716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of torasemide, a new loop diuretic.
    Brater DC; Leinfelder J; Anderson SA
    Clin Pharmacol Ther; 1987 Aug; 42(2):187-92. PubMed ID: 3608350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics and pharmacodynamics of loop diuretics in renal failure.
    Risler T; Schwab A; Kramer B; Braun N; Erley C
    Cardiology; 1994; 84 Suppl 2():155-61. PubMed ID: 7954539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of torasemide in congestive heart failure.
    Kramer WG
    Cardiology; 1994; 84 Suppl 2():108-14. PubMed ID: 7954532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update: prolonged-release torasemide].
    Acuña C
    Drugs Today (Barc); 2010 Jul; 46 Suppl E():1-15. PubMed ID: 20882198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry and pharmacological properties of the pyridine-3-sulfonylurea derivative torasemide.
    Delarge J
    Arzneimittelforschung; 1988 Jan; 38(1A):144-50. PubMed ID: 3370058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of torasemide in man.
    Neugebauer G; Besenfelder E; von Möllendorff E
    Arzneimittelforschung; 1988 Jan; 38(1A):164-6. PubMed ID: 3370063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torasemide in advanced renal failure.
    Kindler J
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():75-80. PubMed ID: 8435381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver.
    Brunner G; von Bergmann K; Häcker W; von Möllendorff E
    Arzneimittelforschung; 1988 Jan; 38(1A):176-9. PubMed ID: 3285830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
    Kido H; Ohtaki Y
    Nihon Yakurigaku Zasshi; 2001 Aug; 118(2):97-105. PubMed ID: 11530685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats.
    Kim EJ; Lee MG
    Biopharm Drug Dispos; 2003 Jan; 24(1):27-35. PubMed ID: 12516076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torasemide. An update of its pharmacological properties and therapeutic efficacy.
    Dunn CJ; Fitton A; Brogden RN
    Drugs; 1995 Jan; 49(1):121-42. PubMed ID: 7705212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and risks of torasemide in congestive heart failure and essential hypertension.
    Brater DC
    Drug Saf; 1996 Feb; 14(2):104-20. PubMed ID: 8852525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.